Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
about
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsImpact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistanceFrequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic reviewThe structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patientDetection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis.Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant TuberculosisImpact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis.Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and MoxifloxacinRole of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical IsolatesSystematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.Use of computed tomography imaging during long-term follow-up of nine feline tuberculosis cases.Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.
P2860
Q28480855-98AB162B-0242-4A95-A636-D9F0C2492DDCQ28484360-B19E48E8-9A44-42B9-9E5B-69F6D2D0B4EAQ28545095-52D0E099-0D1C-4783-BA30-EC9EADDC56CDQ33616718-5BA4C3EF-D5A1-4095-8BC9-B8821FBBA265Q34466858-87354132-617B-4789-85D5-77C90C658032Q34738488-9274F713-4F66-4FDA-9051-2DCADF17EDADQ35076978-C272D2B3-6C40-4802-8215-3B9FB6D5E126Q35960685-AAD85BEF-6BC5-4007-9590-CF4BC76FF692Q36037140-A7D1BDA1-7115-4F46-8FEC-3B49AAD44A6FQ36933151-082797B5-EBA5-4970-8515-327AEA684E06Q37120071-579BB19E-AECA-48BE-81AA-FF817A1E7F89Q37124036-912C38ED-46EB-47A1-8144-FCF06A9A9CB6Q37203747-467C451E-403E-4DD1-8C69-659DEE87C7C5Q37203798-BAC0328E-FE0A-4C96-B635-FB1E6DCA18D2Q37458296-BE2C5FD5-D981-46F4-81E1-6E67B5AB56ECQ37544551-B51F8E1C-B1E5-41AC-B770-6A6D5A6CB8F3Q37682208-BC6BEA75-91CA-48EC-9540-BD5DF4947AB3Q39398946-8BF29B44-F894-46BC-BAAC-0728A4149EDCQ40645861-E5F4B5E8-62CD-41F2-B1E6-683690C45274Q47836600-E6DBAA16-A539-45F8-B39C-DB313A7CD65DQ49798259-C1ECD343-7F74-4667-B45D-FD834D138C61Q55091455-A76EB85D-431E-421D-B65F-1C2B99D8C744
P2860
Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Extending the definition of th ...... resistance in M. tuberculosis.
@ast
Extending the definition of th ...... resistance in M. tuberculosis.
@en
type
label
Extending the definition of th ...... resistance in M. tuberculosis.
@ast
Extending the definition of th ...... resistance in M. tuberculosis.
@en
prefLabel
Extending the definition of th ...... resistance in M. tuberculosis.
@ast
Extending the definition of th ...... resistance in M. tuberculosis.
@en
P2093
P2860
P921
P356
P1476
Extending the definition of th ...... resistance in M. tuberculosis
@en
P2093
Alexandra Aubry
Alix Pantel
Claudine Mayer
Florence Brossier
Sylvaine Bastian
Vincent Jarlier
P2860
P304
P356
10.1128/AAC.06272-11
P407
P577
2012-01-30T00:00:00Z